T790M

Results: 11



#Item
1Citation: Molecular Therapy—Nucleic Acids, e150;  doi:mtna © 2014 The American Society of Gene & Cell Therapy  All rights reservedwww.nature.com/mtna Overcoming EGFR T790M-bas

Citation: Molecular Therapy—Nucleic Acids, e150;  doi:mtna © 2014 The American Society of Gene & Cell Therapy  All rights reservedwww.nature.com/mtna Overcoming EGFR T790M-bas

Add to Reading List

Source URL: www.ibms.sinica.edu.tw

Language: English - Date: 2015-08-05 05:36:36
    2CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

    CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

    Add to Reading List

    Source URL: gotoper-com.s3.amazonaws.com

    Language: English - Date: 2016-06-03 12:14:22
    3ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

    ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

    Add to Reading List

    Source URL: www.zailaboratory.com

    Language: English - Date: 2015-11-24 01:50:17
    4Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016

    Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016

    Add to Reading List

    Source URL: www.biodesix.com

    Language: English - Date: 2016-05-02 01:40:22
    5TAGRISSO (osimertinib) tablet, for oral use

    TAGRISSO (osimertinib) tablet, for oral use

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2015-11-13 09:14:43
    6HHS Public Access Author manuscript Author Manuscript Cancer Discov. Author manuscript; available in PMC 2016 January 01. Published in final edited form as:

    HHS Public Access Author manuscript Author Manuscript Cancer Discov. Author manuscript; available in PMC 2016 January 01. Published in final edited form as:

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    7Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed

    Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2011-08-23 09:57:30
    8Published Ahead of Print on February 11, 2013 asJCOThe latest version is at http://jco.ascopubs.org/cgi/doiJCOJOURNAL OF CLINICAL ONCOLOGY R E V I E W

    Published Ahead of Print on February 11, 2013 asJCOThe latest version is at http://jco.ascopubs.org/cgi/doiJCOJOURNAL OF CLINICAL ONCOLOGY R E V I E W

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2013-02-12 09:06:44
    9ORIGINAL ARTICLE Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer Jasmine Foo, PhD,* Juliann Chmielecki, PhD,† William Pao

    ORIGINAL ARTICLE Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer Jasmine Foo, PhD,* Juliann Chmielecki, PhD,† William Pao

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2012-10-16 11:34:15
    10Downloaded from genome.cshlp.org on October 7, Published by Cold Spring Harbor Laboratory Press Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell

    Downloaded from genome.cshlp.org on October 7, Published by Cold Spring Harbor Laboratory Press Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2013-10-07 10:43:04